Trending...
- California: Governor Newsom signs legislation 7.3.25
- California: Governor Newsom proclaims Independence Day 2025
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
Patient-founded nonprofit seeks to stimulate innovative research to improve outcomes for patients with ROS1+ cancers.
SACRAMENTO, Calif. - Californer -- The ROS1ders is pleased to issue their inaugural Request for Application (RFA) to study ROS1-positive (ROS1+) cancer.
"ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer and other types of cancer," said Janet Freeman-Daily, MS, co-founder and president of The ROS1ders. "While oral targeted therapies are approved to treat it, the drugs don't work for everyone, and they eventually stop working. We need more research to improve quality of life and survival for all patients with this disease."
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward research projects focused on ROS1+ cancer. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or non-profit research institution anywhere in the world.
More on The Californer
"Seed grants, as the name suggests, allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the real seeds of breakthroughs."
The award program uses a two-step application process. An applicant must first submit a letter of intent (LOI) due March 31, 2023. A subset of those applicants will be invited to submit a full application due June 15, 2023. Award recipients will be announced in late summer. For more information, visit https://theros1ders.org/seed-grant-program.
More on The Californer
About the ROS1ders
The ROS1ders, Inc. is a non-profit public benefit corporation that brings together a global group of patients and their family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Founded in 2015 by ROS1+ lung cancer patients, it is the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries. The organization is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Please visit theros1ders.org to learn more.
"ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer and other types of cancer," said Janet Freeman-Daily, MS, co-founder and president of The ROS1ders. "While oral targeted therapies are approved to treat it, the drugs don't work for everyone, and they eventually stop working. We need more research to improve quality of life and survival for all patients with this disease."
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward research projects focused on ROS1+ cancer. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or non-profit research institution anywhere in the world.
More on The Californer
- Colbert Packaging Announces WBENC Recognition
- New Mobile Car Detailing Platform Connects Drivers with On-Demand Local Pros
- Over the past three months, California seized $476 million worth of unlicensed cannabis products
- California scores more clean energy records: 9 in 10 days this year partially powered by 100% clean energy
- "Mobile Suit Gundam" Takes Over San Diego Comic-Con 2025
"Seed grants, as the name suggests, allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the real seeds of breakthroughs."
The award program uses a two-step application process. An applicant must first submit a letter of intent (LOI) due March 31, 2023. A subset of those applicants will be invited to submit a full application due June 15, 2023. Award recipients will be announced in late summer. For more information, visit https://theros1ders.org/seed-grant-program.
More on The Californer
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Hamilton Zanze Sponsors the Acquisition of Two Garden-Style Communities in Reno Area
- Meet a Scientologist Captures Greece's Timeless Beauty with Videographer Lambros Malamas
About the ROS1ders
The ROS1ders, Inc. is a non-profit public benefit corporation that brings together a global group of patients and their family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Founded in 2015 by ROS1+ lung cancer patients, it is the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries. The organization is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Please visit theros1ders.org to learn more.
Source: The ROS1ders, Inc.
Filed Under: Health, Non-profit
0 Comments
Latest on The Californer
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Local Pub Grows Unique Community Ownership Program
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
- California: Acting Governor Eleni Kounalakis proclaims Disability Pride Month
- CHRIS EDMONDS JOINS CITY NATIONAL BANK AS EXECUTIVE VICE PRESIDENT, HEAD OF COMMERCIAL AND NATIONAL CORPORATE BANKING
- Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
- California: $35 million to law enforcement partners to keep communities safe from impaired driving
- Curtis Sergeant's Book The Only One Continues to Equip Christians to Live Fully in by and for God
- IFYA Announces New Froyo Heaven Art Contest
- BKM Capital Partners Publishes Case Study on Hughes Airport Center, Showcasing Strategic Value-Add Execution in Las Vegas
- Miami Real Estate Agent Drastically Increases Interest In Homes
- Adostics & Genmega Announce the Introduction of A-POD
- Auto Careers Online Secures Top Dealers' Choice Award for Eighth Consecutive Year
- MANTL Becomes First Fintech to Offer Plaid Layer
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- California: Governor Newsom commits $101 million to jumpstart critical rebuilding efforts after LA Fires
- Stash Proof Launches Free Shipping on All Orders Nationwide
- John Duffy Hosts Sister Irene O' Neill, Founder and President, and Kelly Mallon Young
- Changzhou Huifeng Vehicle Parts Factory expands U.S. distribution operations
- California: Governor Newsom announces additional crews to assist Texas search and rescue operations